rs143631464
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_012431.3(SEMA3E):c.1855C>T(p.Arg619Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000179 in 1,612,944 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R619H) has been classified as Uncertain significance.
Frequency
Consequence
NM_012431.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SEMA3E | NM_012431.3 | c.1855C>T | p.Arg619Cys | missense_variant | 16/17 | ENST00000643230.2 | |
SEMA3E | NM_001178129.2 | c.1675C>T | p.Arg559Cys | missense_variant | 16/17 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SEMA3E | ENST00000643230.2 | c.1855C>T | p.Arg619Cys | missense_variant | 16/17 | NM_012431.3 | P1 | ||
SEMA3E | ENST00000642232.1 | c.1855C>T | p.Arg619Cys | missense_variant | 16/17 | ||||
SEMA3E | ENST00000643441.1 | n.1840C>T | non_coding_transcript_exon_variant | 16/17 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 151838Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000757 AC: 19AN: 251110Hom.: 0 AF XY: 0.0000884 AC XY: 12AN XY: 135724
GnomAD4 exome AF: 0.000183 AC: 268AN: 1461106Hom.: 0 Cov.: 31 AF XY: 0.000173 AC XY: 126AN XY: 726876
GnomAD4 genome AF: 0.000138 AC: 21AN: 151838Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74124
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, no assertion criteria provided | literature only | OMIM | Oct 14, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 27, 2023 | Observed in siblings with Kallman syndrome who were also heterozygous for a variant in the CHD7 gene, and observed in a patient with CHARGE syndrome who inherited the variant from an unaffected heterozygous parent (PMID: 25985275, 15235037); Published in vitro functional studies demonstrate a damaging effect on protein function (PMID: 25985275); In silico analysis supports that this missense variant does not alter protein structure/function; Variants in candidate genes are classified as variants of uncertain significance in accordance with ACMG guidelines (PMID: 25741868); This variant is associated with the following publications: (PMID: 29144511, 15235037, 25985275) - |
CHARGE syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Mar 02, 2023 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 619 of the SEMA3E protein (p.Arg619Cys). This variant is present in population databases (rs143631464, gnomAD 0.01%). This missense change has been observed in individual(s) with CHARGE syndrome (PMID: 15235037). ClinVar contains an entry for this variant (Variation ID: 221681). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SEMA3E protein function. Experimental studies have shown that this missense change affects SEMA3E function (PMID: 25985275). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
SEMA3E-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 03, 2023 | The SEMA3E c.1855C>T variant is predicted to result in the amino acid substitution p.Arg619Cys. This variant has been reported in two siblings with Kallmann syndrome; however, they also had a variant in CHD7 (p.Phe1019Cys) (Cariboni et al. 2015. PubMed ID: 25985275; Xu et al. 2018. PubMed ID: 29144511). It has also been reported in a child with CHARGE syndrome and their unaffected mother (Lalani et al. 2004. PubMed ID: 15235037). In vitro cell culture assays found this variant was unable to protect cells from cell death (Cariboni et al. 2015. PubMed ID: 25985275). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at